Inventor · disambiguated record
Michael R. Degraffenreid
Also filed as: DEGRAFFENREID MICHAEL · DEGRAFFENREID MICHAEL R
11 granted patents·1 pending application·92 citations·filing 2002–2018
85Inventor score
Top patents by PatentIndex Score
12 records- 0193US7199119B2Antiinflammation agentsAMGEN INC·Filed 2003·Granted Apr 3, 2007·75 cites·11 claims
- 0286US7635695B2Antiinflammation agentsAMGEN INC·Filed 2007·Granted Dec 22, 2009·10 cites·20 claims
- 0381US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 0479US7605289B2Benzamide derivatives and uses related theretoAMGEN INC·Filed 2006·Granted Oct 20, 2009·4 cites·42 claims
- 0561US7365075B2Aryl sulfonamide compounds and uses related theretoAMGEN INC·Filed 2004·Granted Apr 29, 2008·1 cites·46 claims
- 0660US7834047B2Arylsulfonamides and uses related theretoAMGEN INC·Filed 2008·Granted Nov 16, 2010·0 cites·11 claims
- 0759US8637576B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2009·Granted Jan 28, 2014·0 cites·4 claims
- 0851US7495012B2Arylsulfonamides and uses related theretoAMGEN INC·Filed 2005·Granted Feb 24, 2009·0 cites·21 claims
- 0946US2016002185A1Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Application pending·0 cites
- 1044US8772296B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2007·Granted Jul 8, 2014·0 cites·23 claims
- 1143US11407721B2CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2018·Granted Aug 9, 2022·0 cites·46 claims
- 1240US7176314B2Inflammation modulatorsAMGEN INC·Filed 2002·Granted Feb 13, 2007·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when Michael R. Degraffenreid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →